Lagos University Teaching Hospital is a tertiary hospital established in 1961 and is located in Idi-Araba, Surulere, Lagos State, the administrative division of Nigeria. The teaching hospital affiliated with the University of Lagos College of Medicine established in 1962.

There are 761 beds in Lagos University Teaching Hospital.

During the past decade, Lagos University Teaching Hospital conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lagos University Teaching Hospital" #1 sponsor was "Lagos State University" with 5 trials, followed by "Chinese University of Hong Kong" with 2 trials sponsored, "Dr. Olumide ABIODUN" with 1 trials sponsored, "Global Blood Therapeutics" with 1 trials sponsored and "Julia Xu" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lagos University Teaching Hospital" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Lagos State University" with 2 trials as a collaborator, "University of Lagos, Nigeria" with 2 trials as a collaborator, "Aliko Dangote Foundation" with 1 trials as a collaborator and "American Society of Hematology" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Lagos University Teaching Hospital" are "Breast Cancer" (2 trials), "Sickle Cell Disease" (2 trials), "Abdominal Surgery" (1 trials), "Adolescent HIV Infection" (1 trials) and "Anemia" (1 trials). Many other conditions were trialed in "Lagos University Teaching Hospital" in a lesser frequency.

Most popular intervention types in "Lagos University Teaching Hospital" are "Drug" (8 trials), "Other" (5 trials), "Dietary Supplement" (4 trials), "Behavioral" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "10%povidone-iodine + coated suture" (1 trials), "10%povidone-iodine + non-coated suture" (1 trials), "2% chlorhexidine + coated suture" (1 trials), "2% chlorhexidine + non-coated suture" (1 trials) and "Artificial Intelligence enabled electrocardiogram (AI-ECG)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lagos University Teaching Hospital" are 9 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Lagos University Teaching Hospital". 1 are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Lagos University Teaching Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lagos University Teaching Hospital, 4 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".